Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study From Five Local Healthcare Units in the Lombardy Region of Italy

PLoS ONE - United States
doi 10.1371/journal.pone.0082990
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Patent Medicines and Advertisers

American Journal of Public Health and the Nations Health
1938English

Towards a Patent Pool for HIV Medicines: The Background

Open AIDS Journal
EnvironmentalPublic HealthInfectious DiseasesVirologyOccupational Health
2010English

Biosimilar Medicines: Creating Sustainable Competition in an Era of a New Patent Cliff in Biological Medicines

Journal of Pharmaceutical Policy and Practice
ToxicologyPharmaceuticsPharmacologyHealth Policy
2015English

A Critique of an Argument Against Patent Rights for Essential Medicines

Ethics and Global Politics
SociologyInternational RelationsPolitical Science
2014English

Traditional Chinese Patent Medicines for Cancer Treatment in China: A Nationwide Medical Insurance Data Analysis

Oncotarget
Oncology
2015English

Smart Recommendation System for Off-The Shelf Medicines

International Journal of Engineering and Technology(UAE)
ArchitectureHardwareEngineeringChemical EngineeringBiotechnologyEnvironmental EngineeringComputer Science
2018English

DNA Based Identification of Medicinal Materials in Chinese Patent Medicines

Scientific Reports
Multidisciplinary
2012English

Consumer Choice Between Common Generic and Brand Medicines in a Country With a Small Generic Market

Journal of managed care & specialty pharmacy
Health PolicyPharmacyPharmaceutical Science
2015English

The Management of the Home Distribution System of Patent Medicines in the 19th Century:

Keiei Shigaku (Japan Business History Review)
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy